Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1328015

registered interest
date	25/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they will publish the latest evidence base which has led to the B1.351 COVID-19 variant being categorised as a variant of concern, particularly in regard to its transmissibility.
tabling member printed	Lord Oates
uin	HL580
answer	answer is ministerial correction date of answer 03/06/2021 answer text <p>The B.1.351 COVID-19 variant was categorised as a variant of concern (VOC) on 23 December 2020 by the New and Emerging Respiratory Virus Threats Advisory Group. The decision to raise this lineage to a VOC was taken on the basis of reports indicating that the strain had replaced pre-existing strains in parts of South Africa and that there were two cases of B.1.351 identified in the United Kingdom with links to travel from South Africa. The genetic variations identified in the spike protein of B.1.351 were also cause for concern.</p><p>The three substitutions in the receptor binding domain, and in particular the E484K substitution, were thought to result in weaker neutralisation by some monoclonal antibodies and polyclonal neutralising sera. Although at the time there was no formal modelling from South Africa, the rapid spread of the variant could be consistent with increased transmissibility, which was also biologically plausible. More recent data has shown that B.1.351 has greater transmissibility than the original Wuhan strains of the virus. Evaluation was at an early stage when the recommendation to escalate this lineage was taken. A copy of PHE Risk assessment for SARS-CoV-2 variant: VOC-202012/02 (origin: South Africa) of 23 December is attached.</p> answering member printed Lord Bethell question first answered 03/06/2021 11:13:19 answering member 4708 label Biography information for Lord Bethell attachment 1 file name HL580 20201223_VOC-202012 02_SARS-COV-2 variant risk assessment tool_v2.0.docx title PHE Risk assessment for SARS-CoV-2 variant
tabling member	4549 label Biography information for Lord Oates

1328016

registered interest
date	25/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what scientific evidence they have on the effectiveness of the (1) Pfizer, and (2) Astra Zeneca, vaccines in reducing (a) hospitalisations, and (b) symptomatic infections, linked to the B1.351 COVID-19 variant; and what plans they have to publish this evidence.
tabling member printed	Lord Oates
uin	HL581
answer	answer is ministerial correction date of answer 10/06/2021 answer text <p>Public Health England (PHE) is researching the effectiveness of the Pfizer and AstraZeneca vaccines against the B1.351 variant. PHE will publish advice in the weekly COVID-19 vaccine surveillance report once sufficient data is available.</p> answering member printed Lord Bethell question first answered 10/06/2021 11:56:58 answering member 4708 label Biography information for Lord Bethell
tabling member	4549 label Biography information for Lord Oates

1328017

registered interest
date	25/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to cooperate with the scientific community of South Africa on genomic sequencing relating to COVID-19.
tabling member printed	Lord Oates
uin	HL582
answer	answer is ministerial correction date of answer 03/06/2021 answer text <p>The United Kingdom has large-scale sequencing capacity and extensive specialist expertise and is uniquely positioned to help address global sequencing capability gaps. Through the New Variant Assessment Platform (NVAP) programme, Public Health England (PHE) will work to support global partners to strengthen their genomic sequencing capability, either by building on existing infrastructure or by conducting sequencing and analysis of samples in the UK if there is no in-country capability.</p><p>The NVAP will also enable the biological assessment of emerging variants, strengthening horizon scanning and public health decision-making, both in this country and abroad. This includes a risk assessment from the point when a mutation is first identified, to ongoing assessment as more information becomes available. The platform will also agree pathways for biological analysis, diagnostics, vaccines and therapeutics as appropriate. PHE is working with the Africa Centres for Disease Control and Prevention to deploy a Technical Advisor for regional level support.</p> answering member printed Lord Bethell question first answered 03/06/2021 10:08:50 answering member 4708 label Biography information for Lord Bethell
tabling member	4549 label Biography information for Lord Oates

1327196

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Protective Clothing: Health Hazards
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they are aware of any research on the effects of continuous mask-wearing over long periods; and if so what are the findings of that research.
tabling member printed	Lord Farmer
uin	HL481
answer	answer is ministerial correction date of answer 02/06/2021 answer text <p>Public Health England has not conducted any research nor conducted a review of research evidence on this topic.</p> answering member printed Lord Bethell question first answered 02/06/2021 12:51:16 answering member 4708 label Biography information for Lord Bethell
tabling member	4321 label Biography information for Lord Farmer

1327209

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pain
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how they will ensure that those seeking support for managing pain are offered a choice of options through the NHS including mindfulness-based therapies, to reduce the proportion of treatments that rely on medication and the risk of overprescribing.
tabling member printed	Baroness Healy of Primrose Hill
uin	HL498
answer	answer is ministerial correction date of answer 21/06/2021 answer text <p>The National Institute for Health and Care Excellence’s (NICE) guideline, <em>Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain</em>, published in April 2021, recommends a range of pharmacological and non-pharmacological treatment options for pain management. NICE found there was insufficient evidence on mindfulness to recommend it as an option for pain management within this guideline. However, it made recommendations for research on mindfulness to inform future guidance. A copy of NICE’s guideline is attached.</p><p>The National Health Service is also taking a holistic approach to supporting people’s health and wellbeing by expanding its social prescribing services. This enables general practitioners to refer people to community groups and agencies for practical, emotional and social support, for example when managing pain.</p> answering member printed Lord Bethell question first answered 21/06/2021 11:10:11 answering member 4708 label Biography information for Lord Bethell attachment 1 file name NICE Chronic Pain Guidance (1).pdf title NICE Guideline
tabling member	4179 label Biography information for Baroness Healy of Primrose Hill

1327216

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vitamin D
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 1 February (HL12508), what assessment they have made of the recommendation of the Irish Joint Committee on Health for people in that country to take a daily dose of Vitamin D at least two times higher than the dose recommended by Public Health England; and what steps they intend to take as a result.
tabling member printed	Baroness Lister of Burtersett
uin	HL512
answer	answer is ministerial correction date of answer 03/06/2021 answer text <p>Public Health England has not made a formal assessment.</p> answering member printed Lord Bethell question first answered 03/06/2021 10:45:19 answering member 4708 label Biography information for Lord Bethell
tabling member	4234 label Biography information for Baroness Lister of Burtersett

1327218

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government which documents set out the triage policy in relation to a pandemic for (1) hospitals, and (2) care homes, as of January 2020.
tabling member printed	Lord Mann
uin	HL514
answer	answer is ministerial correction date of answer 30/06/2021 answer text <p>Re-configuring service delivery to ensure sufficient National Health Service capacity was central to our preparedness for a pandemic and the COVID-19 response. However, the Department does not have - and did not have in January 2020 - a pandemic triage policy for hospitals and care homes, as this is a clinical matter. In the event that patient triage becomes necessary, clinical guidance would be produced to support decision-making.</p> answering member printed Lord Bethell question first answered 30/06/2021 13:10:38 answering member 4708 label Biography information for Lord Bethell
tabling member	1387 label Biography information for Lord Mann

1327220

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Debts
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government which 10 UK hospitals have the highest financial deficit, including debts carried over from previous years.
tabling member printed	Lord Mann
uin	HL516
answer	answer is ministerial correction date of answer 07/06/2021 answer text <p>During the last year, the government agreed a number of measures to improve the finances in the NHS provider sector in England. These included writing off £13.4 billion of NHS debt, as part of a major financial reset for NHS providers; temporary arrangements that saw trusts receive block payments to fund their spending through the pandemic, supported by c£18bn of additional funding to support the NHS response to COVID. As a result, the amount and levels of deficits across in the NHS provider sector fell significantly.</p><p>Work is ongoing to support the minority of trusts who ended 2020/21 in a deficit position and to develop solutions to secure future financial sustainability.</p><p>Final deficit figures for 2020-21 will be published as part of the NHS’s final accounts in due course.</p> answering member printed Lord Bethell question first answered 07/06/2021 14:13:49 answering member 4708 label Biography information for Lord Bethell
tabling member	1387 label Biography information for Lord Mann

1327226

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diamorphine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 29 April (HL15336), what assessment they have made of the supply of diamorphine; what steps they are taking to ensure that any shortage in the availability of diamorphine to NHS patients is addressed; and when they expect any such shortage to end.
tabling member printed	Lord Pearson of Rannoch
uin	HL528
answer	answer is ministerial correction date of answer 02/06/2021 answer text <p>The Department is aware of ongoing supply issues resulting in intermittent availability of diamorphine injections, due to manufacturing issues. Further supplies of diamorphine injections are expected to be available in June. The Department continues to work closely with all suppliers and the National Health Service to maintain supply to patients who require it. The Department has communicated this issue to the NHS, advising the need to move to alternative opioids where diamorphine is currently used.</p> answering member printed Lord Bethell question first answered 02/06/2021 12:49:18 answering member 4708 label Biography information for Lord Bethell
tabling member	3153 label Biography information for Lord Pearson of Rannoch

1327241

registered interest
date	24/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Local Improvement Finance Trust
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the contribution of the NHS Local Improvement Finance Trust (LIFT) programme to the NHS since its inception.
tabling member printed	Lord Bradley
uin	HL464
answer	answer is ministerial correction date of answer 03/06/2021 answer text <p>The Local Improvement Finance Trust programme set up in 2001 has secured investment of over £2.5 billion to deliver 350 high quality, modern primary care and community facilities and supporting the integration of local services for the benefit of patients. The portfolio provides well maintained and flexible clinical space for over 1,400 individual general practitioner practices, dentists, community services, acute trusts, pharmacies and other healthcare professionals.</p> answering member printed Lord Bethell question first answered 03/06/2021 10:48:34 answering member 4708 label Biography information for Lord Bethell
tabling member	452 label Biography information for Lord Bradley